Brief: Foghorn Therapeutics Q3 EPS USD -0.34
02/11/2023 11:00
Nov 02 (Reuters) - Foghorn Therapeutics Q3 net income USD -14.345 million. * Q3 collaboration revenue USD 17.478 million
FHTX — Foghorn Therapeutics News Story
0.000.00%
Last trade - 00:00- $118.77m
- -$48.81m
- $30.91m